Cutler Group LP Alnylam Pharmaceuticals, Inc. Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$170.77 - $211.65 $256,155 - $317,475	1,500 New	1,500 $265,000
Q1 2023 May 01, 2023	BUY	$182.66 - $235.53 $109,596 - $141,318	600 New	600 $120,000
Q4 2021 Jan 18, 2022	BUY	$159.56 - $209.29 $1.85 Million - $2.42 Million	11,582 New	11,582 $1.96 Million
Q3 2021 Oct 26, 2021	SELL	$169.75 - $207.73 $203,700 - $249,276	-1,200 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$128.63 - $176.89 $347,301 - $477,602	-2,700 Reduced 69.23%	1,200 $203,000
Q4 2019 Feb 06, 2020	BUY	$74.51 - $124.23 $27,047 - $45,095	363 Added 10.26%	3,900 $449,000
Q3 2019 Oct 28, 2019	SELL	$70.9 - $87.82 $134,710 - $166,858	-1,900 Reduced 34.95%	3,537 $284,000
Q2 2019 Aug 09, 2019	BUY	$65.86 - $92.79 $193,430 - $272,524	2,937 Added 117.48%	5,437 $394,000
Q1 2019 May 10, 2019	SELL	$72.76 - $93.45 $12,733 - $16,353	-175 Reduced 6.54%	2,500 $233,000
Q4 2018 Feb 05, 2019	SELL	$62.67 - $88.33 $12,910 - $18,195	-206 Reduced 7.15%	2,675 $195,000
Q3 2018 Nov 07, 2018	SELL	$87.52 - $122.67 $78,768 - $110,403	-900 Reduced 23.8%	2,881 $252,000
Q2 2018 Aug 10, 2018	SELL	$88.31 - $107.8 $80,362 - $98,098	-910 Reduced 19.4%	3,781 $372,000
Q1 2018 May 11, 2018	SELL	$115.92 - $148.54 $4.63 Million - $5.93 Million	-39,944 Reduced 89.49%	4,691 $558,000
Q4 2017 Jan 17, 2018	BUY	$114.49 - $139.98 $214,783 - $262,602	1,876 Added 4.39%	44,635 $5.67 Million
Q3 2017 Oct 17, 2017	BUY	$72.53 - $118.27 $3.1 Million - $5.06 Million	42,759	42,759 $5.02 Million

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.